Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)

China flag China · Delayed Price · Currency is CNY
4.080
0.00 (0.00%)
At close: Mar 10, 2026
51.67%
Market Cap 8.42B
Revenue (ttm) 1.29B
Net Income (ttm) -308.33M
Shares Out 2.06B
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,133,649
Average Volume 88,370,800
Open 4.110
Previous Close 4.080
Day's Range 4.050 - 4.150
52-Week Range 2.140 - 4.830
Beta 0.43
RSI 54.37
Earnings Date Apr 23, 2026

About SHE:300267

Hunan Er-Kang Pharmaceutical Co., Ltd engages in the research and development, production, and sale of pharmaceutical excipients, APIs and finished drugs in China and internationally. The company offers various APIs, such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. It also provides finished drugs, including sulbenicillin sodium for injection and compound liquorice tablets. In addition, the company offers conventional pharmaceutica... [Read more]

Sector Healthcare
Founded 2003
Employees 1,453
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300267
Full Company Profile

Financial Performance

In 2024, SHE:300267's revenue was 1.14 billion, a decrease of -36.09% compared to the previous year's 1.78 billion. Losses were -373.37 million, 91.2% more than in 2023.

Financial Statements

News

There is no news available yet.